Enveric Biosciences, Inc. ENVB 深 沪
交易中 05-11 11:03:27 美东时间
2.875
+0.024
+0.84%
华盛通- 最 高3.50
- 今 开2.74
- 成交量 7.66万股
- 最 低 2.68
- 昨 收 2.851
- 总市值 15.15万
- 52周最高 13.25
- 市盈率 静 --
- 换手率 145.48%
- 52周最低 0.5606
- 委 比 47.84%
- 总股本 5.27万
- 历史最高 300.00
- 量 比 0.65
- 振 幅 28.76%
- 历史最低 0.14
- 每 手 1
- 风险率 1.88%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order
Enveric BioSciences Inc. shares are soaring on Monday after President Trump order to accelerate approvals for psychedelic treatments.
04-21 03:26
US Stocks Mixed; Cleveland-Cliffs Shares Fall After Q1 Results
US stocks mixed, energy shares climb. Cleveland-Cliffs falls 6% after reporting Q1 results. Enveric Biosciences, Fitness Champs, Clearmind Medicine surge.
04-20 22:08
Enveric Biosciences Q4 EPS $(0.50) Up From $(57.96) YoY
Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.50) per share. This is a 99.14 percent increase over losses of $(57.96) per share from the same period last year.
03-28 05:52
Enveric Biosciences Announces Patent Issuance Of U.S. Patent No. 12,492,179 Entitled, "Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives"
U.S. Patent expands the scope of patent protection and increases the number of molecules that Enveric has the potential to develop or license for the treatment of neuropsychiatric conditions.
2025-12-29 21:08
Enveric Biosciences Announces Immediate Warrant Exercise, Raising ~$3.1M Gross Proceeds At Reduced $7.05/Share Price
Enveric Biosciences, Inc. (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced
2025-12-12 02:46
Crude Oil Moves Lower; Photronics Shares Surge After Q4 Results
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaini...
2025-12-11 01:19
What Sparked Enveric Biosciences (ENVB) 74% Surge In After-Hours Trading?
Enveric Biosciences shares soared 73.82% in after-hours trading after the company received a patent allowance for its EVM301 Series molecules.
2025-12-10 11:31
'DEA Calls For Massive Increases In Psilocybin, Ibogaine And THC Manufacturing This Year To Meet Research Demands' - Marijuana Moment
https://www.marijuanamoment.net/dea-calls-for-massive-increases-in-psilocybin-ibogaine-and-thc-manufacturing-this-year-to-meet-research-demands/The Drug Enforcement Administration (DEA) is proposing a dramatic increase
2024-09-24 01:41
Enveric Biosciences Granted US Patent #12065404 Today For "C4-CARBOXYLIC ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS USED TO TREAT BRAIN NEUROLOGICAL DISORDERS".
https://ppubs.uspto.gov/pubwebapp/external.html?q=(12065404).pn
2024-08-21 03:54
